Codexis Stock Performance
| CDXS Stock | USD 4.34 0.01 0.23% |
On a scale of 0 to 100, Codexis holds a performance score of 11. The firm shows a Beta (market volatility) of 2.07, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Codexis will likely underperform. Please check Codexis' potential upside, and the relationship between the jensen alpha and accumulation distribution , to make a quick decision on whether Codexis' price patterns will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Codexis are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Codexis unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.77 | Five Day Return 17.11 | Year To Date Return 42.63 | Ten Year Return 84.65 | All Time Return (66.44) |
1 | Acquisition by Singhvi Rahul of 31347 shares of Codexis subject to Rule 16b-3 | 09/06/2024 |
2 | Acquisition by Dilly Stephen George of 58479 shares of Codexis at 1.7263 subject to Rule 16b-3 | 09/13/2024 |
3 | Disposition of 35714 shares by John Nicols of Codexis at 1.97 subject to Rule 16b-3 | 09/17/2024 |
4 | Acquisition by Opaleye Management Inc. of 45000 shares of Codexis at 3.01 subject to Rule 16b-3 | 09/20/2024 |
5 | Insider Trading | 09/30/2024 |
6 | Codexis increases cash reserves appoints Georgia Erbez as CFO | 10/02/2024 |
7 | Acquisition by Georgia Erbez of 50000 shares of Codexis subject to Rule 16b-3 | 10/10/2024 |
8 | Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting | 10/24/2024 |
9 | Acquisition by Opaleye Management Inc. of 25000 shares of Codexis at 2.9088 subject to Rule 16b-3 | 10/25/2024 |
10 | 10/30/2024 |
11 | Codexis Q3 Earnings Snapshot | 10/31/2024 |
12 | Earnings call Codexis reports revenue growth and strategic focus in Q3 2024 | 11/01/2024 |
13 | Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics | 11/14/2024 |
| Begin Period Cash Flow | 116 M |
Codexis |
Codexis Relative Risk vs. Return Landscape
If you would invest 316.00 in Codexis on August 24, 2024 and sell it today you would earn a total of 118.00 from holding Codexis or generate 37.34% return on investment over 90 days. Codexis is currently generating 0.5852% in daily expected returns and assumes 4.0817% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Codexis, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Codexis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Codexis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Codexis, and traders can use it to determine the average amount a Codexis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1434
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CDXS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.08 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.59 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Codexis is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Codexis by adding it to a well-diversified portfolio.
Codexis Fundamentals Growth
Codexis Stock prices reflect investors' perceptions of the future prospects and financial health of Codexis, and Codexis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Codexis Stock performance.
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.96) % | ||||
| Operating Margin | (1.29) % | ||||
| Current Valuation | 303.96 M | ||||
| Shares Outstanding | 81.38 M | ||||
| Price To Earning | (16.02) X | ||||
| Price To Book | 4.80 X | ||||
| Price To Sales | 5.47 X | ||||
| Revenue | 70.14 M | ||||
| Gross Profit | 20.46 M | ||||
| EBITDA | (49.28 M) | ||||
| Net Income | (76.24 M) | ||||
| Cash And Equivalents | 90.11 M | ||||
| Cash Per Share | 1.38 X | ||||
| Total Debt | 16.02 M | ||||
| Debt To Equity | 0.29 % | ||||
| Current Ratio | 4.84 X | ||||
| Book Value Per Share | 0.90 X | ||||
| Cash Flow From Operations | (52.64 M) | ||||
| Earnings Per Share | (0.88) X | ||||
| Market Capitalization | 352.37 M | ||||
| Total Asset | 136.56 M | ||||
| Retained Earnings | (497.53 M) | ||||
| Working Capital | 57.64 M | ||||
| Current Asset | 32.84 M | ||||
| Current Liabilities | 14.84 M | ||||
About Codexis Performance
Assessing Codexis' fundamental ratios provides investors with valuable insights into Codexis' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Codexis is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 76.51 | 53.39 | |
| Return On Tangible Assets | (0.57) | (0.54) | |
| Return On Capital Employed | (0.68) | (0.71) | |
| Return On Assets | (0.56) | (0.53) | |
| Return On Equity | (0.88) | (0.84) |
Things to note about Codexis performance evaluation
Checking the ongoing alerts about Codexis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Codexis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Codexis appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 70.14 M. Net Loss for the year was (76.24 M) with profit before overhead, payroll, taxes, and interest of 20.46 M. | |
| Codexis currently holds about 90.11 M in cash with (52.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.38. | |
| Over 80.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from globenewswire.com: Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics |
- Analyzing Codexis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Codexis' stock is overvalued or undervalued compared to its peers.
- Examining Codexis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Codexis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Codexis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Codexis' stock. These opinions can provide insight into Codexis' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Codexis Stock Analysis
When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.